Mangoceuticals, Inc. , through its subsidiary MangoRx Mexico, is targeting the ED market in Mexico and Latin America, a region with an untapped potential for ED medications. This strategic move,.
The US FDA has approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder causing hair loss.